{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:51:43Z","timestamp":1791233503741,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2875-13-139","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T11:02:14Z","timestamp":1396954934000},"source":"Crossref","is-referenced-by-count":78,"title":["Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database"],"prefix":"10.1186","volume":"13","author":[{"given":"Patricia","family":"Tabernero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo M","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"3179_CR1","doi-asserted-by":"crossref","DOI":"10.30875\/ac42f7b8-en","volume-title":"World Malaria Report 2012","author":"World Health Organization","year":"2012","unstructured":"World Health Organization: World Malaria Report 2012. 2012, [cited 2013 March, 17th]; Available from: \n                    http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/"},{"key":"3179_CR2","unstructured":"United Nations Human Rights Council: Access to medicines in the context of the right of everyone to the to the enjoyment of the highest attainable standard of physical and mental health. Twenty-third session, Agenda item 3, Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development 2013 [cited 2013 June 20th]; Available from: \n                    http:\/\/ap.ohchr.org\/documents\/dpage_e.aspx?si=A\/HRC\/23\/L.10\/rev.1"},{"issue":"8","key":"3179_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1365-3156.2008.02106.x","volume":"13","author":"JM Caudron","year":"2008","unstructured":"Caudron JM, Ford N, Henkens M, Mac\u00e9 C, Kiddle-Monroe R, Pinel J: Substandard medicines in resource-poor settings: a problem that can no longer be ignored. M\u00e9dicaments sous-standard dans les milieux d\u00e9favoris\u00e9s: un probl\u00e8me qui ne peut plus \u00eatre ignor\u00e9. Revue Medicamentos sub-est\u00e1ndar en lugares con pocos recursos: un problema que no puede ser ignorado por m\u00e1s tiempo. Revisi\u00f3n. Tropical Med Int Health. 2008, 13 (8): 1062-1072. 10.1111\/j.1365-3156.2008.02106.x.","journal-title":"Tropical Med Int Health"},{"key":"3179_CR4","volume-title":"Countering the Problem of Falsified and Substandard Drugs","author":"Institute of Medicine of the National Academies","year":"2013","unstructured":"Institute of Medicine of the National Academies: Countering the Problem of Falsified and Substandard Drugs. 2013, National Academy of Sciences. The National Academies Press, Available from: \n                    http:\/\/www.iom.edu\/reports\/2013\/countering-the-problem-of-falsified-and-substandard-drugs.aspx"},{"key":"3179_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1475-2875-10-352","volume":"10","author":"PN Newton","year":"2011","unstructured":"Newton PN, Green MD, Mildenhall DC, Plancon A, Nettey H, Nyadong L, Hostetler DM, Swamidoss I, Harris GA, Powell K, Timmermans AE, Amin AA, Opuni SK, Barbereau S, Faurant C, Soong RCW, Faure K, Thevanayagam J, Fernandes P, Kaur H, Angus B, Stepniewska K, Guerin PJ, Fernandez FM: Poor quality vital antimalarials in Africa \u2013 an urgent neglected public health priority. Malar J. 2011, 10: 352-10.1186\/1475-2875-10-352.","journal-title":"Malar J"},{"issue":"5","key":"3179_CR6","doi-asserted-by":"publisher","first-page":"e1544","DOI":"10.1371\/journal.pntd.0001544","volume":"6","author":"TPC Dorlo","year":"2012","unstructured":"Dorlo TPC, Eggelte TA, Schoone GJ, de Vries PJ, Beijnen JH: A Poor-Quality Generic Drug for the Treatment of Visceral Leishmaniasis: A Case Report and Appeal. PLoS Negl Trop Dis. 2012, 6 (5): e1544-10.1371\/journal.pntd.0001544.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9821","key":"3179_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(12)60277-3","volume":"379","author":"S Nishtar","year":"2012","unstructured":"Nishtar S: Pakistan's deadly cocktail of substandard drugs. Lancet. 2012, 379 (9821): 1084-5. 10.1016\/S0140-6736(12)60277-3.","journal-title":"Lancet"},{"key":"3179_CR8","volume-title":"Report on the investigation of the quality of diminazene preparations in sub-Saharan Africa in Report prepared under a Special Services Agreement to investigate the quality of veterinary trypanocides in sub-Saharan Africa","author":"Food & Agricultural Organisation of the United Nations (FAO)","year":"2001","unstructured":"Food & Agricultural Organisation of the United Nations (FAO): Report on the investigation of the quality of diminazene preparations in sub-Saharan Africa in Report prepared under a Special Services Agreement to investigate the quality of veterinary trypanocides in sub-Saharan Africa. Edited by: Tettey JNA. 2001, Food & Agricultural Organisation of the United Nations,"},{"issue":"2","key":"3179_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1179\/204777312X13419245939520","volume":"106","author":"P Tabernero","year":"2012","unstructured":"Tabernero P, Newton PN: The WWARN Antimalarial Quality Surveyor. Pathog Glob Health. 2012, 106 (2): 77-78. 10.1179\/204777312X13419245939520.","journal-title":"Pathog Glob Health"},{"key":"3179_CR10","volume-title":"Counterfeit Version of Avastin in U.S. Distribution","author":"U.S. Food & Drug Administration (FDA)","year":"2012","unstructured":"U.S. Food & Drug Administration (FDA): Counterfeit Version of Avastin in U.S. Distribution. 2012, [cited 2012 February, 14]; Available from: \n                    http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm291960.htm"},{"key":"3179_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1473-3099(06)70581-3","volume":"6","author":"PN Newton","year":"2006","unstructured":"Newton PN, Green MD, Fernandez FM, Day NP, White NJ: Counterfeit anti-infective drugs. Lancet Infect Dis. 2006, 6: 602-613. 10.1016\/S1473-3099(06)70581-3.","journal-title":"Lancet Infect Dis"},{"key":"3179_CR12","volume-title":"Observations on the superior efficacy of the Red Peruvian Bark","author":"W Saunders","year":"1782","unstructured":"Saunders W: Letter from Dr Edward Rigby, Norwich, 8th September 1782. Vol. 4th edition. Observations on the superior efficacy of the Red Peruvian Bark. 1782, London, UK: J Johnson & J Murray"},{"key":"3179_CR13","first-page":"169","volume":"59","author":"WJ Heath","year":"2004","unstructured":"Heath WJ: America\u2019s First Drug Regulation Regime: The Rise and Fall of the Import Drug Act of 1848. Food Drug Law J. 2004, 59: 169-200.","journal-title":"Food Drug Law J"},{"issue":"147","key":"3179_CR14","first-page":"413","volume":"6","author":"A GP","year":"1826","unstructured":"GP A:Drug Adulteration. Lancet. 1826, 6 (147): 413-","journal-title":"Lancet"},{"issue":"794","key":"3179_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(02)82655-1","volume":"31","author":"CJ Croft","year":"1838","unstructured":"Croft CJ:Adulteration Quinine. Lancet. 1838, 31 (794): 292-10.1016\/S0140-6736(02)82655-1.","journal-title":"Lancet"},{"key":"3179_CR16","volume-title":"BMJ","author":"A Attaran","year":"2012","unstructured":"Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, Martin McKee M: How to achieve international action on falsified and substandard medicines. BMJ. 2012, 345:"},{"issue":"12","key":"3179_CR17","doi-asserted-by":"publisher","first-page":"e1001139","DOI":"10.1371\/journal.pmed.1001139","volume":"8","author":"PN Newton","year":"2011","unstructured":"Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, Simons B, Bate R, Guerin PJ, White NJ: The Primacy of Public Health Considerations in Defining Poor Quality Medicines. PLoS Med. 2011, 8 (12): e1001139-10.1371\/journal.pmed.1001139.","journal-title":"PLoS Med"},{"key":"3179_CR18","first-page":"74","volume-title":"Amending Directive 2001\/83\/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products., in Directive 2011\/62\/EU Of The European Parliament And Of","author":"European Union","year":"2011","unstructured":"European Union: Amending Directive 2001\/83\/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products., in Directive 2011\/62\/EU Of The European Parliament And Of The Council. 2011, Official Journal of the European Union, 74-87. Available from: \n                    http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/dir_2011_62\/dir_2011_62_en.pdf\n                    \n                  ,"},{"issue":"9751","key":"3179_CR19","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/S0140-6736(10)61416-X","volume":"376","author":"R Bate","year":"2010","unstructured":"Bate R, Attaran A: A counterfeit drug treaty: Great idea, wrong implementation. Lancet. 2010, 376 (9751): 1446-1448. 10.1016\/S0140-6736(10)61416-X.","journal-title":"Lancet"},{"key":"3179_CR20","volume-title":"Substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products: report of the Working Group of Member States. Sixty-fifth World Health Assembly. Provisional Agenda item 13.13 A65\/23","author":"WHO","year":"2012","unstructured":"WHO: Substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products: report of the Working Group of Member States. Sixty-fifth World Health Assembly. Provisional Agenda item 13.13 A65\/23. 2012, WHO,Available from:\n                    http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA65\/A65_23-en.pdf\n                    \n                  ,"},{"issue":"2","key":"3179_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jrs.1621","volume":"38","author":"M de Veij","year":"2007","unstructured":"de Veij M, Vandenabeele P, Hall KA, Fernandez FM, Green MD, White NJ, Dondorp AM, Newton PN, Moens L: Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopy. J Raman Spectrosc. 2007, 38 (2): 181-187. 10.1002\/jrs.1621.","journal-title":"J Raman Spectrosc"},{"issue":"2","key":"3179_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.aca.2008.06.007","volume":"623","author":"C Ricci","year":"2008","unstructured":"Ricci C, Nyadong L, Yang F, Fernandez FM, Brown CD, Newton PN, Kazarian SG: Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal Chim Acta. 2008, 623 (2): 178-186. 10.1016\/j.aca.2008.06.007.","journal-title":"Anal Chim Acta"},{"issue":"5","key":"3179_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00216-007-1543-1","volume":"389","author":"C Ricci","year":"2007","unstructured":"Ricci C, Eliasson C, Macleod N, Newton P, Matousek P, Kazarian S: Characterization of genuine and fake artesunate anti-malarial tablets using Fourier transform infrared imaging and spatially offset Raman spectroscopy through blister packs. Anal Bioanal Chem. 2007, 389 (5): 1525-1532. 10.1007\/s00216-007-1543-1.","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"3179_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/cmdc.200600041","volume":"1","author":"FM Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN: Characterization of Solid Counterfeit Drug Samples by Desorption Electrospray Ionization and Direct-analysis-in-real-time Coupled to Time-of-flight Mass Spectrometry. ChemMedChem. 2006, 1 (7): 702-705. 10.1002\/cmdc.200600041.","journal-title":"ChemMedChem"},{"issue":"15","key":"3179_CR25","first-page":"3073","volume":"136","author":"FM Fernandez","year":"2010","unstructured":"Fernandez FM, Hostetler D, Powell K, Kaur H, Green MD, Mildenhall DC, Newton PN: Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries. R Soc of Chem. 2010, 136 (15): 3073-3082.","journal-title":"R Soc of Chem"},{"issue":"1","key":"3179_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/thy.09.84","volume":"7","author":"H Kaur","year":"2010","unstructured":"Kaur H, Green MD, Hostetler DM, Fernandez FM, Newton PN: Antimalarial drug quality: Methods to detect suspect drugs. Therapy. 2010, 7 (1): 49-57. 10.2217\/thy.09.84.","journal-title":"Therapy"},{"issue":"5","key":"3179_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ: Artemisinin Resistance in Plasmodium falciparum Malaria. N Engl J Med. 2009, 361 (5): 455-467. 10.1056\/NEJMoa0808859.","journal-title":"N Engl J Med"},{"issue":"1","key":"3179_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1475-2875-8-253","volume":"8","author":"N White","year":"2009","unstructured":"White N, Pongtavornpinyo W, Maude R, Saralamba S, Aguas R, Stepniewska K, Lee S, Dondorp A, White L, Day N: Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009, 8 (1): 253-10.1186\/1475-2875-8-253.","journal-title":"Malar J"},{"issue":"3","key":"3179_CR29","doi-asserted-by":"publisher","first-page":"0252","DOI":"10.1371\/journal.pmed.1000052","volume":"6","author":"PN Newton","year":"2009","unstructured":"Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegardh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ: Guidelines for field surveys of the quality of medicines: A proposal. PLoS Med. 2009, 6 (3): 0252-0257.","journal-title":"PLoS Med"},{"key":"3179_CR30","volume-title":"Antimalarial Quality Surveyor","author":"Worldwide Antimalarial Resistance Network, A.Q.S.G","year":"2012","unstructured":"Worldwide Antimalarial Resistance Network, A.Q.S.G: Antimalarial Quality Surveyor. 2012, [cited 2013 December 12th]; Available from: \n                    http:\/\/www.wwarn.org\/resistance\/surveyors\/antimalarial-quality"},{"key":"3179_CR31","volume-title":"Antimalarial Quality Surveyor. Methodology","author":"Worldwide Antimalarial Resistance Network, A.Q.S.G","year":"2012","unstructured":"Worldwide Antimalarial Resistance Network, A.Q.S.G: Antimalarial Quality Surveyor. Methodology. 2012, [cited 2013 December 16th]; Available from: \n                    http:\/\/www.wwarn.org\/resistance\/surveyors\/antimalarial-quality\/methodology"},{"issue":"4","key":"3179_CR32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4269\/ajtmh.2008.78.552","volume":"78","author":"V Keoluangkhot","year":"2008","unstructured":"Keoluangkhot V, Green MD, Nyadong L, Fern\u00e1ndez FM, Mayxay M, Newton PN: Impaired Clinical Response in a Patient with Uncomplicated Falciparum Malaria Who Received Poor-Quality and Underdosed Intramuscular Artemether. AmJTrop Med Hyg. 2008, 78 (4): 552-555.","journal-title":"AmJTrop Med Hyg"},{"issue":"10","key":"3179_CR33","doi-asserted-by":"publisher","first-page":"e3403","DOI":"10.1371\/journal.pone.0003403","volume":"3","author":"H Kaur","year":"2008","unstructured":"Kaur H, Goodman C, Thompson E, Thompson K-A, Masanja I, Kachur SP, Abdulla S: A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania. PLoS One. 2008, 3 (10): e3403-10.1371\/journal.pone.0003403.","journal-title":"PLoS One"},{"issue":"1","key":"3179_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1475-2875-8-22","volume":"8","author":"O Onwujekwe","year":"2009","unstructured":"Onwujekwe O, Kaur H, Dike N, Shu E, Uzochukwu B, Hanson K, Okoye V, Okonkwo P: Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malar J. 2009, 8 (1): 22-10.1186\/1475-2875-8-22.","journal-title":"Malar J"},{"issue":"12","key":"3179_CR35","first-page":"692","volume":"75","author":"JW Ogwal-Okeng","year":"1998","unstructured":"Ogwal-Okeng JW, Okello DO, Odyek O: Quality of oral and parenteral chloroquine in Kampala. East Afr Med J. 1998, 75 (12): 692-694.","journal-title":"East Afr Med J"},{"issue":"9272","key":"3179_CR36","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0140-6736(00)05065-0","volume":"357","author":"RB Taylor","year":"2001","unstructured":"Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA: Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet. 2001, 357 (9272): 1933-1936. 10.1016\/S0140-6736(00)05065-0.","journal-title":"Lancet"},{"issue":"1","key":"3179_CR37","first-page":"161","volume":"2","author":"MA Odeniyi","year":"2003","unstructured":"Odeniyi MA: Comparative analysis of eight brands of sulfadoxinepyrimethamine tablets. Trop J Pharm Res. 2003, 2 (1): 161-167.","journal-title":"Trop J Pharm Res"},{"key":"3179_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1475-2875-8-172","volume":"8","author":"S Sengaloundeth","year":"2009","unstructured":"Sengaloundeth S, Green MD, Fernandez FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN: A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J. 2009, 8: 172-10.1186\/1475-2875-8-172.","journal-title":"Malar J"},{"key":"3179_CR39","unstructured":"IPR in China: Judicial Protection of IPR in China. GlaxoSmithKline Case Study. Intellectual Property Rights in China 2000 December 2000 [cited March 3rd, 2013]; Available from: \n                    http:\/\/www.chinaiprlaw.com\/english\/news\/news14.htm"},{"issue":"6","key":"3179_CR40","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1371\/journal.pmed.0030197","volume":"3","author":"PN Newton","year":"2006","unstructured":"Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJM, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ: Manslaughter by Fake Artesunate in Asia-Will Africa Be Next?. PLoS Med. 2006, 3 (6): e197-10.1371\/journal.pmed.0030197.","journal-title":"PLoS Med"},{"key":"3179_CR41","volume-title":"Counteracting Counterfeiting: Strategies for Improving the Integrity of the Medicinal Marketplace in Tanzania","author":"M Ndomondo-Sigonda","year":"2005","unstructured":"Ndomondo-Sigonda M: Counteracting Counterfeiting: Strategies for Improving the Integrity of the Medicinal Marketplace in Tanzania. 2005, Tanzania Food and Drugs Authority, Available from: \n                    http:\/\/projects.msh.org\/seam\/reports\/fip-cairo_2005\/57_counteracting.pdf"},{"key":"3179_CR42","unstructured":"News MG: Pharmacia Withdraws Metakelfin in White Sachets. modern.ghana.com 2002 [cited 2011 November, 7th]; Available from: \n                    http:\/\/www.modernghana.com\/news\/20469\/1\/pharmacia-withdraws-metakelfin-in-white-sachets.html"},{"key":"3179_CR43","volume-title":"Africa Health","author":"MM Sesay","year":"1988","unstructured":"Sesay MM: Fake drugs- A new threat to health-care delivery. Africa Health. 1988"},{"issue":"1","key":"3179_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1475-2875-6-22","volume":"6","author":"M Gaudiano","year":"2007","unstructured":"Gaudiano M, Di Maggio A, Cocchieri E, Antoniella E, Bertocchi P, Alimonti S, Valvo L: Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. Malar J. 2007, 6 (1): 22-10.1186\/1475-2875-6-22.","journal-title":"Malar J"},{"issue":"3","key":"3179_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4269\/ajtmh.2004.70.245","volume":"70","author":"LK Basco","year":"2004","unstructured":"Basco LK: Molecular Epidemiology of Malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. AmJTrop Med Hyg. 2004, 70 (3): 245-250.","journal-title":"AmJTrop Med Hyg"},{"key":"3179_CR46","volume-title":"Fake drugs hit Ugandan market","author":"D Mugabe","year":"2009","unstructured":"Mugabe D: Fake drugs hit Ugandan market. 2009, [cited 2012 October 8th]"},{"issue":"2","key":"3179_CR47","first-page":"23","volume":"4","author":"WO Erhun","year":"2001","unstructured":"Erhun WO, Babalola OO, Erhun MO: Drug Regulation and Control in Nigeria: The Challenge of Counterfeit Drugs. J Health Popul Dev Ctries. 2001, 4 (2): 23-24.","journal-title":"J Health Popul Dev Ctries"},{"key":"3179_CR48","unstructured":"Alter K, Fern\u00e1ndez F, Green M, Newton PN: Analysis of counterfeit antimalarial drugs. Eur Pharm Rev. 2004, 2004 (3):"},{"issue":"5","key":"3179_CR49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.2006.75.804","volume":"75","author":"KA Hall","year":"2006","unstructured":"Hall KA, Newton PN, Green MD, De Veij M, Vandenabeele P, Pizzanelli D, Mayxay M, Dondorp A, Fern\u00e1ndez FM: Characterization of Counterfeit Artesunate antimalarial tablets from Southeast Asia. AmJTrop Med Hyg. 2006, 75 (5): 804-811.","journal-title":"AmJTrop Med Hyg"},{"key":"3179_CR50","volume-title":"3 held over fake malaria drugs","author":"A Bagala","year":"2008","unstructured":"Bagala A: 3 held over fake malaria drugs. 2008, [cited 2012 December 20th]; Available from: \n                    http:\/\/www.monitor.co.ug\/News\/Education\/-\/688336\/759052\/-\/view\/printVersion\/-\/13hs21sz\/-\/index.html"},{"issue":"9259","key":"3179_CR51","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(05)71830-4","volume":"357","author":"J Rozendaal","year":"2001","unstructured":"Rozendaal J: Fake antimalaria drugs in Cambodia. Lancet. 2001, 357 (9259): 890-890.","journal-title":"Lancet"},{"key":"3179_CR52","volume-title":"Substandard and counterfeit medicines","author":"D Bagozzi","year":"2003","unstructured":"Bagozzi D: Substandard and counterfeit medicines. 2003, WHO, Fact sheet 275. Available from: \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/2003\/fs275\/en\/"},{"issue":"3","key":"3179_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/rcm.893","volume":"17","author":"J-C Wolff","year":"2003","unstructured":"Wolff J-C, Thomson LA, Eckers C: Identification of the \u2018wrong\u2019 active pharmaceutical ingredient in a counterfeit Halfan\u2122 drug product using accurate mass electrospray ionisation mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography\/mass spectrometry. Rapid Commun Mass Spectrom. 2003, 17 (3): 215-221. 10.1002\/rcm.893.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3179_CR54","unstructured":"The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2013, ICH, [cited 2013 August 20th]; Available from: \n                    http:\/\/www.ich.org\/"},{"key":"3179_CR55","volume-title":"Prequalification Programme. A United Nations Programme managed by WHO","author":"WHO","year":"2013","unstructured":"WHO: Prequalification Programme. A United Nations Programme managed by WHO. 2013, [cited 2013 February 8th]; Available from: \n                    http:\/\/apps.who.int\/prequal\/"},{"issue":"4","key":"3179_CR56","doi-asserted-by":"publisher","first-page":"0302","DOI":"10.1371\/journal.pmed.0020100","volume":"2","author":"R Cockburn","year":"2005","unstructured":"Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ: Global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Med. 2005, 2 (4): 0302-0308.","journal-title":"PLoS Med"},{"key":"3179_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(10)62319-7","volume":"377","author":"The Lancet Editorial","year":"2011","unstructured":"The Lancet Editorial: Editorial, Fighting fake drugs: the role of WHO and pharma. Lancet. 2011, 377: 1-10.1016\/S0140-6736(10)62319-7.","journal-title":"Lancet"},{"key":"3179_CR58","first-page":"413","volume":"Chapter 24","author":"PN Newton","year":"2009","unstructured":"Newton PN, Fern\u00e1ndez FM, Green MD, Primo-Carpenter J, White NJ: Counterfeit and Substandard Anti-infectives in Developing Countries. Antimicrob Resist Dev Ctries. 2009, Chapter 24: 413-443.","journal-title":"Antimicrob Resist Dev Ctries"},{"issue":"11","key":"3179_CR59","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3201\/eid1511.090886","volume":"15","author":"T Leslie","year":"2009","unstructured":"Leslie T, Kaur H, Mohammed N, Kolaczinski K, Ord RL, Rowland M: Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. Emerg Infect Dis. 2009, 15 (11): 1753-1759. 10.3201\/eid1511.090886.","journal-title":"Emerg Infect Dis"},{"key":"3179_CR60","first-page":"118","volume-title":"Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa","author":"J Sabartova","year":"2011","unstructured":"Sabartova J, Toumi A, World Health Organization: Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. 2011, WHO, 118-Available from: \n                    http:\/\/www.who.int\/entity\/medicines\/publications\/WHO_QAMSA_report.pdf"},{"issue":"6","key":"3179_CR61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","volume":"12","author":"GML Nayyar","year":"2012","unstructured":"Nayyar GML, Breman JG, Newton PN, Herrington J: Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012, 12 (6): 488-496. 10.1016\/S1473-3099(12)70064-6.","journal-title":"Lancet Infect Dis"},{"key":"3179_CR62","volume-title":"Saving lives, buying time: economics of malaria drugs in an age of resistance","author":"KJ Arrow","year":"2004","unstructured":"Arrow KJ, Panosian CB, Gelband H: Saving lives, buying time: economics of malaria drugs in an age of resistance. Edited by: Committee on the Economics of Antimalarial Drugs Board on Global Health. Institute of Medicine of the National Academies. 2004, Washington D.C: The National Academies Press"},{"issue":"7341","key":"3179_CR63","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/bmj.324.7341.800","volume":"324","author":"PN Newton","year":"2002","unstructured":"Newton PN, White NJ, Rozendaal JA, Green MD: Murder by fake drugs: Time for international action. Br Med J. 2002, 324 (7341): 800-801. 10.1136\/bmj.324.7341.800.","journal-title":"Br Med J"},{"key":"3179_CR64","volume-title":"Second Meeting of the Member State Mechanism on Substandard,Spurious,Falsely-labelled,Falsified,Counterfeit Medical Products. Provisional Agenda item. Vol. A\/MSM\/2\/3","author":"WHO","year":"2013","unstructured":"WHO: Report of the Open-ended Working Group to Identify the Actions, Activities and Behaviours that Result in Substandard\/Spurious\/Falsely-labelled\/Falsified\/Counterfeit Medical Products. Second Meeting of the Member State Mechanism on Substandard,Spurious,Falsely-labelled,Falsified,Counterfeit Medical Products. Provisional Agenda item. Vol. A\/MSM\/2\/3. 2013, World Health Organization, Available from: \n                    http:\/\/apps.who.int\/gb\/ssffc\/pdf_files\/A_MSM2_3-en.pdf"},{"key":"3179_CR65","volume-title":"Provisional agenda item 3. Report by the Secretariat. Vol. A\/MSM\/WG\/1\/2","author":"WHO","year":"2013","unstructured":"WHO:Open-ended working group to identify the actions, activities and behaviours that result in substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products.Provisional agenda item 3. Report by the Secretariat. Vol. A\/MSM\/WG\/1\/2. 2013, World Health Organization, Available from: \n                    http:\/\/apps.who.int\/gb\/ssffc\/pdf_files\/WG1b\/A_MSM_WG1_2-en.pdf\n                    \n                  ,"},{"key":"3179_CR66","volume-title":"First Meeting of the Member State Mechanism on Substandard\/Spurious\/Falsely-labelled\/Falsified\/Counterfeit Medical Products. Provisional Agenda item 4","author":"WHO","year":"2012","unstructured":"WHO: WHO, Substandard\/Spurious\/Falsely-labelled\/Falsified\/Counterfeit medical products. Situation report by the Secretariat. First Meeting of the Member State Mechanism on Substandard\/Spurious\/Falsely-labelled\/Falsified\/Counterfeit Medical Products. Provisional Agenda item 4. 2012, World Health Organization, Available from: \n                    http:\/\/apps.who.int\/gb\/ssffc\/pdf_files\/A_MSM1_INF1-en.pdf"},{"key":"3179_CR67","volume-title":"First meeting of the Member State Mechanism on Substandard,Spurious,Falsely-labelled,Falsified,Counterfeit medical products. Provisional Agenda item 6","author":"WHO","year":"2012","unstructured":"WHO: Options for the structure and governance of the Member State mechanism on substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products. First meeting of the Member State Mechanism on Substandard,Spurious,Falsely-labelled,Falsified,Counterfeit medical products. Provisional Agenda item 6. 2012, World Health Organization, Available from: \n                    http:\/\/apps.who.int\/gb\/ssffc\/pdf_files\/A_MSM1_3-en.pdf"},{"key":"3179_CR68","volume-title":"Substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products. Report by the Secretariat in Sixty-sixth World Health Assembly. Provisional agenda item 17.1","author":"WHO","year":"2013","unstructured":"WHO: Substandard\/spurious\/falsely-labelled\/falsified\/counterfeit medical products. Report by the Secretariat in Sixty-sixth World Health Assembly. Provisional agenda item 17.1. 2013, World Health Organization, Available from: \n                    http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA66\/A66_22-en.pdf\n                    \n                  ,"},{"key":"3179_CR69","first-page":"115","volume-title":"WHO Drug Information. Quality and Safety of Medicines","author":"WHO","year":"2013","unstructured":"WHO: WHO project for the surveillance and monitoring of SSFFC medical products. WHO Drug Information. Quality and Safety of Medicines. 2013, 115-"},{"key":"3179_CR70","volume-title":"WHO List of Prequalified Quality Control Laboratories","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: WHO List of Prequalified Quality Control Laboratories. Version 26th Edition 2013 [cited 2013 August 20th]; Available from: \n                    http:\/\/www.who.int\/prequal\/lists\/pq_qc\n                    \n                  labs list.pdf"},{"key":"3179_CR71","volume-title":"World Malaria Report 2011","author":"WHO","year":"2011","unstructured":"WHO: World Malaria Report 2011. 2011, World Health Organization, [cited 2013 March, 17th] Available from: \n                    http:\/\/www.who.int\/malaria\/world_malaria_report_2011\/9789241564403_eng.pdf"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-13-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:03:18Z","timestamp":1548118998000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-13-139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3179"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-13-139","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]},"article-number":"139"}}